License Monitoring and Enforcement at NIH Charlene Maddox, Steven Ferguson, Svetlana Smith, Sabarni Chatterjee NIH Research Festival Poster, 2026 |  |
|
HHS License-Based Vaccines and Therapeutics Charlene Maddox, Steven Ferguson, Richelle Holnick NIH Research Festival Poster, 2026 |  |
Careers for Scientists in Technology Transfer and Business Development Steven Ferguson, Krishna Balakrishnan NIH Research Festival Poster, 2026 |  |
|
Recognizing NIH's Role in Turning Discoveries into Cancer Treatments Berna Uygur, Steven Ferguson NIH Research Festival Poster, 2026 |  |
New Portal Empowers NIH Inventors to Manage Royalty Payments Kevin Doran NIH Research Festival Poster, 2026 |  |
|
NIH and the Federal Laboratory Consortium for Technology Transfer (FLC) Steven Ferguson, Sabarni Chatterjee NIH Research Festival Poster, 2026 |  |
How the US Encourages Rare Disease Drug Development Darex Vera-Rodriguez, Michael Salgaller MedNous Vol. XX No. 8 2026, Sep; 10-11 |  |
Recognizing NIH's Role in Turning Discoveries into Cancer Treatments Berna Uygur, Steven Ferguson les Nouvelles Vol. LXI No. 1 2026, Mar; 7-25 |  |
Accelerating Federal Technology Transfer Through a Startup Challenge Licensing Mode Steven Ferguson, Rosemarie Truman, Cody J. Locke les Nouvelles Vol. LXI No. 1 2026, Mar; 36-38 |  |
|
Technology Transfer Magic Sauce Ingredients - When and Where to Use Them Krishna (Balk) Balakrishnan, Suryanarayana (Sury) Vepa, Rebecca Erwin-Cohen, Christopher Dillon, Ami Gadhia les Nouvelles Vol. LXI No. 1 2026, Mar; 52-56 |  |
The U.S. National Institutes of Health: Inspiring Innovation in Biomedicine and Health Steven Ferguson, Michael Salgaller In: UlrichA. K. Betz, ed. Science for a Better Tomorrow. (Springer). 2025: 44-59. |  |
|
The Real Returns on NIH's Intramural Research Jeffrey Alexander, Rossana Zetina-Beale Volume XLI, No. 4, Summer 2025 |  |
Licensing to Improve Global Access to Medicines During Public Health Emergencies and Beyond Ami Gadhia, Steven Ferguson, Mark Rohrbaugh LES Viewpoints Vol. XXXI No. 1 2023 May; 1-3 |  |
|
NCATS Breaks the Mold: Case Studies of Unique Tech Transfer Mechanisms Ami D. Gadhia, Rebecca A. Erwin-Cohen, Krishna (Balki) Balakrishnan, Lili M. Portilla Technology Transfer Tactics. 2022 Sep; 154-158 |  |
Hiding in Plain Sight: Surprising Pharma and Biotech Connections to NIH's National Cancer Institute Berna Uygur, Steven Ferguson, and Michael Pollack J Commer Biotechnol. 2022 Jul 17; 27(2): 5–13. |  |
|
Patnering with the US National Cancer Institute: Research Underway to Treat Rare Brain Cancers Michael Salgaller, Michael Pollack, Michele Newton MedNous. 2021, Jan; 13-15 |  |
| OSA/NCATS Workshop: Expectations and Impact of TT |  |
|
| OSA/NCATS Workshop: Innovation In and Measuring TT |  |
The U.S. National Institutes of Health – Founding A National Biomedical “Innovation Ecosystem” Steven M. Ferguson and Lynn Johnson Langer J Commer Biotechnol. 2021 Mar; 26(1): 72–82. |  |
I-Corps at NIH: Entrepreneurial Training Program Creating Successful Small Businesses Christie A Canaria, Lili Portilla, Michael Weingarten Clin Transl Sci. 2019 Jul;12(4):324-328 |  |
Moving Innovations from the Lab to Patients Michael Salgaller, Michele Newton MedNous. 2019, Mar; 8-9 |  |
|
How SBIR and STTR Can Support Women in Biotech Funding for Innovation from NIH’s Small Business Programs Interview with Lili Portilla In: Association for Women in Science, 2017;49:36-27 |  |
The Commercialization of New Drugs and Vaccines Discovered in Public Sector Research Stevens, A.J., Jensen, J.J., Wyller, K., Kilgore, P.C., London, E., Zhang, Q., Chatterjee, S., and Rohrbaugh, M.L, In: S.M. Breznitz and H. Etzkowitz, eds., Routledge, University Technology Transfer: The Globalization of Academic Innovation, 2016:102-145 |  |
|
NIH Inventions Translate into Drugs and Biologics with High Public Health Impact Sabarni K. Chatterjee and Mark L. Rohrbaugh Nat Biotechnol. 2014 Jan 9;32(1):52-58. |  |
Collaborative Development of 2-hydroxypropyl-β-cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease Lili Portilla Curr Top Med Chem. 2014;14(3):330-339 |  |
|
Leveraging Public Private Partnerships to Innovate Under Challenging Budget Times Lili Portilla and Mark L. Rohrbaugh Curr Top Med Chem. 2014;14(3):326-329 |  |
Partnering with the NIH: Now part of the "Value Proposition" for start-ups Steven M. Ferguson J Commer Biotechnol. 2012 Apr 1;18(2):60-67. |  |
License Compliance Issues for Biopharmaceuticals: Special Challenges for Negotiations between Companies and Non-Profit Research Institutions Todd A. Ponzio, Hans Feindt, and Steven M. Ferguson les Nouvelles, 2011 Sep;46(3):216-25. |  |
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines Ashley J. Stevens, Jonathan J. Jensen, Katrine Wyller, Patrick C. Kilgore, Sabarni Chatterjee, and Mark L. Rohrbaugh N Engl J Med. 2011 Feb 10;364(6):535-41. |  |